These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 16860864

  • 21. WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study.
    Østergaard M, Olesen LH, Hasle H, Kjeldsen E, Hokland P.
    Br J Haematol; 2004 Jun; 125(5):590-600. PubMed ID: 15147374
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Feasibility of using the combined MDS-EVI1/EVI1 gene expression as an alternative molecular marker in acute myeloid leukemia: a report of four cases.
    Weisser M, Haferlach C, Haferlach T, Schnittger S.
    Cancer Genet Cytogenet; 2007 Aug; 177(1):64-9. PubMed ID: 17693194
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. WT1 protein expression in childhood acute leukemia.
    Kerst G, Bergold N, Gieseke F, Coustan-Smith E, Lang P, Kalinova M, Handgretinger R, Trka J, Müller I.
    Am J Hematol; 2008 May; 83(5):382-6. PubMed ID: 18161786
    [Abstract] [Full Text] [Related]

  • 30. Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
    Neudenberger J, Hotfilder M, Rosemann A, Langebrake C, Reinhardt D, Pieters R, Schrauder A, Schrappe M, Röttgers S, Harbott J, Vormoor J.
    Br J Haematol; 2006 May; 133(3):337-44. PubMed ID: 16643437
    [Abstract] [Full Text] [Related]

  • 31. PRAME gene expression in childhood acute lymphoblastic leukemia: impact on prognosis.
    Abdelmalak CA, Yahya RS, Elghannam DM, El-Khadragy AE, Abd El Messih HM.
    Clin Lab; 2014 May; 60(1):55-61. PubMed ID: 24600975
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome.
    Oberthuer A, Hero B, Spitz R, Berthold F, Fischer M.
    Clin Cancer Res; 2004 Jul 01; 10(13):4307-13. PubMed ID: 15240516
    [Abstract] [Full Text] [Related]

  • 34. Comparison of minimal residual disease (MRD) estimated by flow cytometry and by real-time quantitative PCR of Wilms tumor gene 1 (WT1) transcript expression in children with acute lymphoblastic leukemia.
    Chen JS, Hsiao CC, Sheen JM, Cheng CN.
    Leuk Res; 2007 Oct 01; 31(10):1351-7. PubMed ID: 17445885
    [Abstract] [Full Text] [Related]

  • 35. Follow-up of minimal residual disease in acute childhood lymphoblastic leukemia by WT1 gene expression in the peripheral blood: the Hungarian experience.
    Magyarosy E, Varga N, Timár J, Rásó E.
    Pediatr Hematol Oncol; 2003 Oct 01; 20(1):65-74. PubMed ID: 12687755
    [Abstract] [Full Text] [Related]

  • 36. Monitoring of minimal residual disease in acute myeloid leukemia.
    Kern W, Schoch C, Haferlach T, Schnittger S.
    Crit Rev Oncol Hematol; 2005 Nov 01; 56(2):283-309. PubMed ID: 16213150
    [Abstract] [Full Text] [Related]

  • 37. [Studies of hTERT gene expression in acute leukemia children].
    Li X, Wang X, Li X, Liu B, Zhang Y, Liao Q.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul 01; 34(3):486-8. PubMed ID: 12910697
    [Abstract] [Full Text] [Related]

  • 38. Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia.
    Candoni A, Tiribelli M, Toffoletti E, Cilloni D, Chiarvesio A, Michelutti A, Simeone E, Pipan C, Saglio G, Fanin R.
    Eur J Haematol; 2009 Jan 01; 82(1):61-8. PubMed ID: 18801058
    [Abstract] [Full Text] [Related]

  • 39. WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?
    Bader P, Niemeyer C, Weber G, Coliva T, Rossi V, Kreyenberg H, Gerecke A, Biondi A.
    Eur J Haematol; 2004 Jul 01; 73(1):25-8. PubMed ID: 15182334
    [Abstract] [Full Text] [Related]

  • 40. Prevalence and prognostic and predictive relevance of PRAME in breast cancer.
    Doolan P, Clynes M, Kennedy S, Mehta JP, Crown J, O'Driscoll L.
    Breast Cancer Res Treat; 2008 May 01; 109(2):359-65. PubMed ID: 17624586
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.